DK0975775T3 - Regulatorisk system til inducerbar ekspression af gener med lambdapromotorer - Google Patents

Regulatorisk system til inducerbar ekspression af gener med lambdapromotorer

Info

Publication number
DK0975775T3
DK0975775T3 DK98924212T DK98924212T DK0975775T3 DK 0975775 T3 DK0975775 T3 DK 0975775T3 DK 98924212 T DK98924212 T DK 98924212T DK 98924212 T DK98924212 T DK 98924212T DK 0975775 T3 DK0975775 T3 DK 0975775T3
Authority
DK
Denmark
Prior art keywords
antirepressor
promoter
gene coding
genes
gene
Prior art date
Application number
DK98924212T
Other languages
English (en)
Inventor
Nico Maurice Mertens
Erik Rene Remaut
Walter Charles Fiers
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of DK0975775T3 publication Critical patent/DK0975775T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mushroom Cultivation (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DK98924212T 1997-04-23 1998-04-23 Regulatorisk system til inducerbar ekspression af gener med lambdapromotorer DK0975775T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1005884 1997-04-23
PCT/EP1998/002465 WO1998048025A2 (en) 1997-04-23 1998-04-23 Regulatory system for inducible expression of genes with lambdoid promoters

Publications (1)

Publication Number Publication Date
DK0975775T3 true DK0975775T3 (da) 2004-07-26

Family

ID=19764839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924212T DK0975775T3 (da) 1997-04-23 1998-04-23 Regulatorisk system til inducerbar ekspression af gener med lambdapromotorer

Country Status (10)

Country Link
US (1) US6485934B1 (da)
EP (1) EP0975775B1 (da)
JP (1) JP2001526533A (da)
AT (1) ATE262041T1 (da)
AU (1) AU729712B2 (da)
CA (1) CA2287541C (da)
DE (1) DE69822453T2 (da)
DK (1) DK0975775T3 (da)
PT (1) PT975775E (da)
WO (1) WO1998048025A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2511855A1 (en) * 2003-02-21 2004-09-02 Biotecnol S.A. Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
US8026083B2 (en) 2007-04-03 2011-09-27 Oxyrane Uk Limited Yarrowia lipolytica and Pichia pastoris HAC1 nucleic acids
CA2775938C (en) 2009-09-29 2021-08-10 Oxyrane Uk Limited Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
JP2013511272A (ja) 2009-11-19 2013-04-04 オキシレイン ユーケー リミテッド 哺乳類様複合ｎ−グリカンを生成する酵母株
EP2622088A2 (en) 2010-09-29 2013-08-07 Oxyrane UK Limited Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
CN103261432A (zh) 2010-09-29 2013-08-21 奥克西雷恩英国有限公司 磷酸化的n-聚糖的脱甘露糖基化
WO2012170433A1 (en) * 2011-06-08 2012-12-13 Sutro Biopharma, Inc. Multiple rna polymerase terminator cassettes for efficient transcription of discrete rna templates
KR20190114003A (ko) 2012-03-15 2019-10-08 옥시레인 유케이 리미티드 폼페병의 치료를 위한 방법 및 물질
CN112521472B (zh) * 2020-12-04 2023-02-07 海南波莲水稻基因科技有限公司 一种与水稻育性及花器官数目相关的分子标记及其应用
GB202205833D0 (en) * 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319242A1 (de) * 1983-05-27 1984-11-29 Battelle-Institut E.V., 6000 Frankfurt Verfahren und plasmid zur steuerung der expression von klonierten genen
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
US5416008A (en) * 1991-10-01 1995-05-16 California Institute Of Technology Cross-regulation of gene expression in recombinant cells

Also Published As

Publication number Publication date
WO1998048025A2 (en) 1998-10-29
CA2287541C (en) 2010-04-20
US6485934B1 (en) 2002-11-26
ATE262041T1 (de) 2004-04-15
DE69822453D1 (de) 2004-04-22
PT975775E (pt) 2004-07-30
EP0975775B1 (en) 2004-03-17
AU7649198A (en) 1998-11-13
EP0975775A2 (en) 2000-02-02
AU729712B2 (en) 2001-02-08
WO1998048025A3 (en) 1999-01-21
CA2287541A1 (en) 1998-10-29
JP2001526533A (ja) 2001-12-18
DE69822453T2 (de) 2005-03-24

Similar Documents

Publication Publication Date Title
DK0975775T3 (da) Regulatorisk system til inducerbar ekspression af gener med lambdapromotorer
ES2056799T3 (es) Moleculas de adn codante para las regiones de control fmdh y gen estructural para una proteina que tiene una actividad de fmdh y su uso.
ES2194865T3 (es) Amplificacion viral de arn mensajero recombinante en plantas transgenicas.
ATE386811T1 (de) Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
IE872455L (en) Improved recombinant expression
FI871144A (fi) Foerfarande foer framstaellning av proteinprodukter i aspegillus oryzae och en promotor foer anvaendning i aspergillus.
DK0864645T3 (da) Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
ATE224955T1 (de) Verfahren zur genetische einkreisung von pflanzen
ES8305413A1 (es) Un metodo para estabilizar y seleccionar celulas huesped quecontienen un adn recombinante
RS50488B (sr) Vektori ekspresije koji sadrže mcmv ie2 promotor
ATE428790T1 (de) Verbessertes system zur regulation der transgenexpression
DE69535704D1 (de) EXPRESSIONSPLASMIDE, DURCH EINEN osmB PROMOTER REGULIERT
FI923758A0 (fi) Expressionssystem.
DK0953644T3 (da) Systemer til masseproduktion af proteiner eller peptider ved mikroorganismer af slægten Humicola
DK1051502T3 (da) Meget effektiv styret ekspression af eksogene gener i E. coli
DK384185D0 (da) Ekspressionsvektorer
ATE91715T1 (de) Genexpressionssystem.
FI924909A (fi) Biosyntetiskt foerfarande foer framstaellning av kemiska foereningar
ATE220104T1 (de) Expressionssystem zur produktion von proteinen
DE3882455D1 (de) Verfahren zur herstellung von proteinen in loeslicher form.
ATE386114T1 (de) Gene, die für lymphocyte spezifischen interferon- regulationsfaktor (lsirf) polypeptide kodiert
DK0410228T3 (da) Termoinducerbar udtrykkelse af heterologe gener i Bacillus subtilis og midler og fremgangsmåder til opnåelse heraf
ATE474928T1 (de) Verfahren zum herstellen von proteinen in einer hefe der gattung arxula und dafür geeignete promotoren
DK0670904T3 (da) Vektor til ekspression af terapeutisk relevante gener
JPS6486875A (en) Plasmid vector containing streptomycin-sensitive gene